SALT LAKE CITY, Nov. 12 UT-AmedicaCorporation
SALT LAKE CITY, Nov. 12 /PRNewswire/ -- Amedica Corporation, an orthopedic
implants company focused on silicon nitride ceramic technologies, announced
today that it has received a CE (Conformite Europeene) mark for its Valeo(TM)
family of ceramic spinal intervertebral spacers. This family includes
Valeo - C and Valeo - TL spacers made using Amedica's novel silicon nitride
ceramic for surgical correction or stabilization of the spine. This family
received FDA clearance in January 2008, for sale in the United States as
vertebral body replacements.
The Valeo family of ceramic spinal intervertebral spacers is intended to
aid in surgical correction and stabilization of the thoracolumbar spine.
These implants are designed to restore the biomechanical integrity of the
anterior, middle and posterior spine, even in the absence of fusion, for a
prolonged period of time. The Valeo family of spacers provides new
functionalities compared to competing devices currently on the market and is
believed to be the first family of silicon nitride ceramic implants available
for spinal use in the world.
"Amedica's ceramic spinal spacers uniquely combine strength with an
improved bone/implant interface and bone like imaging compatibility, making
them a valuable alternative to currently available devices using conventional
synthetic materials," said Darrel Brodke, M.D., Professor and Vice-Chair,
Director of Spine Service, Department of Orthopaedics, University of Utah
School of Medicine. "Because these implants have a combination of
distinguishing features, I would expect Amedica's implants to be well received
in Europe and Asia, where allograft bone is not frequently used."
"Obtaining the CE mark for our Valeo ceramic spinal spacers expands our
ability to bring our portfolio of innovative spinal implant products to
important markets in Europe, Asia and other regions of the world," said Ashok
Khandkar, Ph.D., Chief Executive Officer of Amedica Corporation. "This
achievement gives us the ability to begin to educate and train physicians in
Europe and other foreign markets so that more patients can benefit from our
innovative implants."
About Amedica
Amedica Corporation is an emerging orthopedic implant company focused on
using its silicon nitride ceramic technologies to develop and commercialize a
broad range of innovative, high-performance spine and joint implants for the
growing orthopedic device market. Its products under development include
spine, reconstructive hip and knee implants that may represent a new standard
of care in total joint implants based on superior durability, performance and
safety.
SOURCE Amedica Corporation